NuCryo Vascular: The Return Of PolarCath For Peripheral Vascular Disease
This article was originally published in Start Up
Despite enthusiastic uptake by cardiologists when it was first introduced, cryoplasty has become the poor relation of the interventional peripheral vascular disease treatment sector. A new version of a pioneering product is back on the market, thanks to start-up NuCryo Vascular.
Register for our free email digests: